Chair: B. Gerull (Würzburg), B. Meder (Heidelberg)
| 14:30 | (V260) | Introduction |
| B. Gerull (Würzburg) | ||
| 14:35 | (V261) | Myosin inhibition – Who benefits most? |
| O. J. Müller (Kiel) | ||
| 14:50 | Discussion | |
| 14:55 | (V262) | Role of altered force generation and allelic imbalances in HCM |
| J. Montag (Hannover) | ||
| 15:10 | Discussion | |
| 15:15 | (V263) | Impaired protein quality control in HCM |
| N. Hamdani (Bochum) | ||
| 15:30 | Discussion | |
| 15:35 | (V264) | Gene therapy in HCM – From preclinical studies to clinical trials |
| L. Carrier (Hamburg) | ||
| 15:50 | Discussion | |
| 15:55 | (V265) | Conclusion |
| B. Meder (Heidelberg) |
| 16:30 - 17:00 | Eröffnung der Herztage in Saal New York |
| 17:00 - 18:30 | Great Debate I in Saal New York |